Ossendorff Robert, Kurth Sarah, Wang Su, Jaenisch Max, Assaf Elio, Scheidt Sebastian, Welle Kristian, Burger Christof, Wirtz Dieter C, Strauss Andreas C, Schildberg Frank A
Department of Orthopedics and Trauma Surgery, University Hospital Bonn, 53127 Bonn, Germany.
Cells. 2024 Dec 31;14(1):30. doi: 10.3390/cells14010030.
Inflammation models with the proinflammatory cytokine interleukin-1β (IL-1β) are widely used in the in vitro investigation of new therapeutic approaches for osteoarthritis (OA). The aim of this study was to systematically analyze the influence of IL-1β in a 3D chondral pellet culture model. Bovine articular chondrocytes were cultured to passage 3 and then placed in pellet culture. Titration of IL-1β (100-0.1 ng/mL) was performed with both human and bovine recombinant protein in chondrocyte culture for 2 weeks. Gene expression of anabolic (collagen 2, aggrecan, cartilage oligomeric protein (COMP), proteoglycan-4 (PRG-4)), catabolic matrix metallo proteinases (MMP-3, MMP-13), dedifferentiation (collagen 1) markers and inflammatory cytokines IL-6 and IL-8 was determined. Analysis of the cell culture medium was performed for the inflammatory markers IL-6 and nitric oxide (NO). In general, the influence of IL-1β was shown by a decrease in the expression of anabolic markers (collagen 2, aggrecan, PRG-4), whereas the catabolic markers MMP-3 and MMP-13 as well as the inflammatory markers IL-6 and IL-8 were significantly increased. This was observed both at the early time point (day 4) and at the late time point (day 14). The described inflammatory effects were confirmed by increased concentration-dependent release of NO and IL-6. The threshold concentration for a detectable effect compared to control differed between groups, but was reached earlier by homologous application of IL-1β. This study provides a systematic evaluation of IL-1β-specific effects on chondrocytes in a 3D pellet culture model, which is highly relevant for comparisons of studies in OA-specific drug development.
含有促炎细胞因子白细胞介素 -1β(IL-1β)的炎症模型被广泛用于骨关节炎(OA)新治疗方法的体外研究。本研究的目的是系统分析IL-1β在三维软骨微球培养模型中的影响。将牛关节软骨细胞培养至第3代,然后进行微球培养。在软骨细胞培养中,用人和牛重组蛋白对IL-1β(100 - 0.1 ng/mL)进行滴定,培养2周。测定合成代谢(胶原蛋白2、聚集蛋白聚糖、软骨寡聚基质蛋白(COMP)、蛋白聚糖 -4(PRG-4))、分解代谢基质金属蛋白酶(MMP-3、MMP-13)、去分化(胶原蛋白1)标志物以及炎性细胞因子IL-6和IL-8的基因表达。对细胞培养基进行炎性标志物IL-6和一氧化氮(NO)的分析。总体而言,IL-1β的影响表现为合成代谢标志物(胶原蛋白2、聚集蛋白聚糖、PRG-4)表达下降,而分解代谢标志物MMP-3和MMP-13以及炎性标志物IL-6和IL-8显著增加。在早期时间点(第4天)和晚期时间点(第14天)均观察到这种情况。NO和IL-6浓度依赖性释放增加证实了上述炎症效应。与对照组相比,可检测效应的阈值浓度在不同组之间有所不同,但通过同源应用IL-1β能更早达到。本研究对三维微球培养模型中IL-1β对软骨细胞的特异性作用进行了系统评估,这对于OA特异性药物开发研究的比较具有高度相关性。